Ex parte MARFAT et al. - Page 3




                 Appeal No. 95-1618                                                                                                                     
                 Application 08/033,456                                                                                                                 


                 or more substituents independently selected from fluoro, chloro, bromo, iodo, hydroxy, (C -C ) alkyl,                                  
                                                                                                                         1   6                          
                 (C -C )  alkoxy  and  thiofluoromethyl;  and  W  is  hydrogen,  (C -C )  alkanoyl,  (C -C )  cyclo-1  3                                                                   2   10                    5   7                          
                 alkylcarbonyl, (C -C ) phenylalkanoyl, chlorobenzoyl, thenoyl, omega-(C -C )-alkoxycarbonyl-(C -7  10                                                            2   4                        3                   
                 C )alkanoyl, (C -C )alkoxycarbonyl, phenoxycarbonyl, 1-[(C -C )acyloxy]-(C -C )alkyl, 1-[(C -71 0                                                                                                               
                   5                2                                                       1   4               2   4              2                   
                 C )alkoxy-carbonyloxy]-(C -C )alkyl, (C -C )-alkylsulfonyl, (C -C )alkyl, methylphenylsulfonyl and5                             1  4            1  3                      1   3                                                        
                 di-(C -C )alkyl phosphonate; with the proviso that (a) when E is nitrogen, then at least one of X and                                  
                       1   3                                                                                                                            
                 Y is other than hydrogen; (b) when either R is NHR or R is (C -C )alkyl, then W is hydrogen;2         6      1      1   6                                                      
                          or a pharmaceutically acceptable salt thereof.                                                                                
                                                                  The Rejections2                                                                       
                          I.       Claims 1-6 and 8-13 stand rejected under 35 U.S.C. § 112, first paragraph, on the                                    
                 grounds that (i) certain amendatory subject matter to the specification in an amendment filed October                                  
                 15, 1993 (Paper No. 25) constitutes new matter in that “by deletion of selected language from the                                      
                 specification and insertion of new formula designations appear to be expanding the scope of the                                        
                 original disclosure whereby new matter is introduced...,” and (ii) the specification fails to provide an                               
                 adequate written description of the invention and fails to adequately provide an enabling disclosure                                   
                 for the following reasons as stated in the final rejection (Paper No. 26, pp. 3-4):                                                    
                                   Applicants*  specification  fails  to  clearly  distinguish  between  tautomer                                       
                          structures.  It is not clear which tautomers are intended.  The originally filed                                              
                          disclosure  appeared  to  intend  a  limited  scope  of  tautomer  structures  however                                        
                          pursuant to applicants* amendment of 10-15-93 a different broader scope appears to                                            


                          2In the final rejection, the examiner rejected claim 8 on the ground that the formula in claim 8 did not have support         
                 in the original disclosure.  The examiner withdrew this rejection in view of appellants’ "suggestion to amend the Formula              
                 in claim 8 so as to recite a hydroxyl group (instead of a single bonded oxygen)" (Answer, p. 2).  Appellants suggested                 
                 amending “the structure of claim 8 such that the oxygen in the 3- position is bonded to a hydrogen since it would be obvious           
                 to one of ordinary skill in the art that said compound as it presently stands would have that chemical structure” (Brief, p. 1).       
                 Appellants also presented a table in the Brief providing page and line numbers in the specification as originally filed for            
                 support for the formula in claim 8 (Brief, pp. 4-7).  It appears to us that despite the suggestion made by appellants which            
                 prompted the examiner to withdrawn this portion of the rejection, the specification on page 6, line 25, as well as original            
                 claim 1, provides support for the formula in claim 8.  Both disclose that W can be hydrogen.                                           
                                                                          -3-                                                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007